EFFECT OF ATYPICAL ANTIPSYCHOTIC PRIOR AUTHORIZATION IMPLEMENTATION ON PATIENT OUTCOMES AMONG OHIO MEDICAID BENEFICIARIES

被引:0
|
作者
Thompson, J. A. [1 ]
Kelton, C. M. [1 ]
Lin, A. C. [1 ]
Winstanley, E. L. [1 ]
Heaton, P. C. [1 ]
机构
[1] Univ Cincinnati, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMH65
引用
收藏
页码:A303 / A304
页数:2
相关论文
共 50 条
  • [1] Discontinuities in atypical antipsychotic therapy following prior authorization and step therapy among medicaid beneficiaries with schizophrenia
    Soumerai, S. B.
    Zhang, F.
    Ross-Degnan, D.
    Ball, D. E.
    Lecates, R. F.
    Law, M. R.
    Hughes, T. E.
    Chapman, D.
    Adams, A. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 64 - 65
  • [2] Medicaid's prior authorization program and access to atypical antipsychotic medications
    Polinski, Jennifer M.
    Wang, Philip S.
    Fischer, Michael A.
    HEALTH AFFAIRS, 2007, 26 (03) : 750 - 760
  • [3] Economic and clinical impacts of prior authorization for antipsychotic and anticonvulsant medications among medicaid beneficiaries with bipolar disorder
    Zhang, Y.
    Adams, A. S.
    Ross-Degnan, D.
    Zhang, F.
    Soumerai, S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 293 - 294
  • [4] Effects of Prior Authorization on Medication Discontinuation Among Medicaid Beneficiaries With Bipolar Disorder
    Zhang, Yuting
    Adams, Alyce S.
    Ross-Degnan, Dennis
    Zhang, Fang
    Soumerai, Stephen B.
    PSYCHIATRIC SERVICES, 2009, 60 (04) : 520 - 527
  • [5] Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications
    Farley, Joel F.
    Cline, Richard R.
    Schommer, Jon C.
    Hadsall, Ronald S.
    Nyman, John A.
    CLINICAL THERAPEUTICS, 2008, 30 (08) : 1524 - 1539
  • [6] Medicaid Prior Authorization Policies for Pediatric Use of Antipsychotic Medications
    Schmid, Ian
    Burcu, Mehmet
    Zito, Julie M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (09): : 966 - 968
  • [7] The Effect of Medicaid Peer Review Prior Authorization Policies on Pediatric Use of Antipsychotic Medications
    Burcu, Mehmet
    Zito, Julie M.
    McKean, Stephen
    Warnock, Rob
    Herbert, Peter
    Verma, Sumit
    Worrall, Chris M.
    Chu, Steve
    Mohamadi, Ali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 16 - 17
  • [8] ASSESSING THE IMPACT OF A MEDICAID PRIOR AUTHORIZATION (PA) POLICY FOR DULOXETINE ON ANTIPSYCHOTIC USE AMONG PATIENTS WITH DEPRESSION
    Birnbaum, H. G.
    Ivanova, J. I.
    Waldman, T.
    Swallow, E.
    Cummings, A. K.
    Clark, T.
    Peng, X.
    Swindle, R.
    VALUE IN HEALTH, 2013, 16 (03) : A68 - A69
  • [9] ASSESSMENT OF PATIENT OUT-OF-POCKET COSTS FOR ANTIPSYCHOTIC TREATMENTS AMONG MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA
    Lin, D.
    Pilon, D.
    Benson, C.
    Morrison, L.
    Shah, A.
    Lafeuille, M. H.
    Lefebvre, P.
    VALUE IN HEALTH, 2021, 24 : S129 - S129
  • [10] ANTIPSYCHOTIC MEDICATION PRESCRIPTION TRENDS IN FOSTER CARE CHILDREN ENROLLED IN ARKANSAS MEDICAID FOLLOWING IMPLEMENTATION OF PRIOR AUTHORIZATION POLICIES
    Simpson, Stacy
    Domon, Steven
    Miller, Laurence H.
    Ford-Bowen, Pamela
    Golden, William
    Thapa, Purushottam
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S201 - S202